- cafead   Jun 08, 2023 at 10:32: AM
via The U.S. Food and Drug Administration has published its warning letter to iRhythm Technologies, revealing inspectors accused the company of failing to seek clearance before making major changes to permitted uses for its Zio AT heart monitor.
article source
article source